Pivotal Role of Artificial Intelligence in Cardiovascular Health: Highlights from the Late Breaking Trials at the AHA Scientific Sessions 2023
Cardiovascular Health
DOI:
10.20944/preprints202403.1471.v1
Publication Date:
2024-03-29T03:32:45Z
AUTHORS (6)
ABSTRACT
Cardiovascular diseases (CVDs) remain the leading cause of mortality. Traditional approaches to diagnosing and treating CVDs often involve interpretation, which can lead errors. The emergence Artificial Intelligence (AI) Machine Learning aids management CVDs. AI examines amounts data identifies patterns offering solutions for disease detection, risk prediction, patient care. American Heart Association's 2023 Scientific Sessions (AHA23) showcased studies that highlight AIs potential revolutionize cardiac healthcare. This article presents a review these cutting-edge exploring how is applied in health, outcomes applications, their implications clinical practice. insights gained from this will contribute discussion on AI's role healthcare its capacity enhance outcomes.
SUPPLEMENTAL MATERIAL
Coming soon ....
REFERENCES (0)
CITATIONS (0)
EXTERNAL LINKS
PlumX Metrics
RECOMMENDATIONS
FAIR ASSESSMENT
Coming soon ....
JUPYTER LAB
Coming soon ....